Who are Exalys Therapeutics's investors?

Exalys Therapeutics's investors include Catalys Pacific, Domain Associates.

How much funding has Exalys Therapeutics raised?

Exalys Therapeutics has disclosed $4M raised across 1 round.

Exalys Therapeutics is headquartered in San Diego, US.

San Diego, US · Founded 2018 · Delaware corporation · 2 known investors

Eckard Weber, M.D.Named on SEC filing

Michael SandersNamed on SEC filing

Nicole VitulloNamed on SEC filing

Dennis Podlesak in 𝕏Named on SEC filingVenture Partner at Domain Associates

Rick OrrNamed on SEC filing

Lynne RollinsNamed on SEC filing

Takeshi Takahashi inBoard directorManaging Director at Catalys Pacific

Brian Taylor SlingsbyBoard directorFounder & Managing Director, MD, PhD, MPH at Catalys Pacific

Form D private placements

$4M disclosed across 1 round · 2020

▶$4MraisedApr 2020 · 2 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

2 people who came through Exalys Therapeutics went on to found or lead other companies.

Who are Exalys Therapeutics's investors?: Exalys Therapeutics's investors include Catalys Pacific, Domain Associates.
How much funding has Exalys Therapeutics raised?: Exalys Therapeutics has disclosed $4M raised across 1 round.
Where is Exalys Therapeutics headquartered?: Exalys Therapeutics is headquartered in San Diego, US.